NEW YORK, Dec. 10, 2022 /PRNewswire/ — The global female contraceptive market has been categorized as a part of the global personal products market. The parent market, the global personal products market, covers products and companies engaged in the research and development (R&D) and production of personal and beauty care products, such as cosmetics and perfumes. The scope of this market also includes personalized gifts, sleep masks, sex toys, hair wigs and extensions, and polarized sunglasses markets.
The female contraceptive market size is forecasted to grow by USD 5,142.22 million from 2022 to 2026. The market is estimated to grow at a CAGR of 5.32% during the forecast period, according to Technavio. Download a sample
Female contraceptive market 2023-2027: Scope
The female contraceptive market report covers the following areas:
Female contraceptive market 2023-2027: Vendor landscape
The global female contraceptive market was fragmented in 2022, with the presence of a large number of international and local players. International players offer a wide range of female contraceptives, while local vendors mainly cater to the demands of consumers with particular preferences. This, in turn, has resulted in intense competition in the market. In addition, various players are engaging in continuous R&D to improve the quality of contraceptives in terms of design and materials, which is further intensifying the competition.
AbbVie Inc., Afaxys Pharma LLC, Agile Therapeutics Inc., Amgen Inc., Ansell Ltd., Bayer AG, CooperSurgical Inc., Cupid Ltd., Exeltis USA Inc., Johnson & Johnson, Mayer Laboratories Inc., Medisafe Distribution Inc., Merck & Co. Inc., Mylan NV, Pfizer Inc., Piramal Enterprises Ltd., Reckitt Benckiser Group PLC, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Veru Inc. are among some of the major market participants.
Female contraceptive market 2023-2027: Competitive analysis
The competitive scenario categorizes companies based on various performance indicators. Some of the factors considered include the financial performance of companies, growth strategies, product innovations, new product launches, investments, growth in market share, among others. Buy the report
Female contraceptive market 2023-2027: Segmentation
- Distribution channel
- Offline
- Online
The offline segment will account for the largest share of the market’s growth during the forecast period. This segment includes merchandisers, drugstores, non-commercial outlets, and others. The growth of merchandisers will be steady during the forecast period due to factors such as rising awareness about female contraceptive products. The preference for drugstores is growing at a significant rate due to the increasing customer confidence in products sold through drugstores or pharmacies in terms of quality, usefulness, safety, and standards.
- Product
- Female contraceptive devices
- Female contraceptive drugs
- Geography
- North America
- APAC
- Europe
- South America
- Middle East And Africa
North America is estimated to account for 38% of the market’s growth during the forecast period. The growth of the market in this region is attributed to factors such as high product penetration and availability. The availability of advanced female contraceptive products such as IUDs is also driving the regional market’s growth. The demand for these products is increasing, as they are considered effective in preventing pregnancies and are cost-effective.
To gain further insights about various segments, Request a PDF sample
What are the key data covered in this female contraceptive market report?
- CAGR of the market during the forecast period
- Detailed information on factors that will drive the growth of the female contraceptive market between 2023 and 2027
- Precise estimation of the size of the female contraceptive market and its contribution to the parent market
- Accurate predictions about upcoming trends and changes in consumer behavior
- Growth of the female contraceptive market across APAC, North America, Europe, Middle East and Africa, and South America
- Thorough analysis of the market’s competitive landscape and detailed information about vendors
- Comprehensive analysis of factors that will challenge the growth of female contraceptive market vendors
Subscribe to our “Basic Plan” billed annually at USD 5000, which enables you to download 5 reports and view 100 reports every month
Related reports:
Feminine hygiene products market by distribution channel, product, and geography – Forecast and analysis 2023-2027: The feminine hygiene products market size is expected to increase by USD 11,407.53 million from 2022 to 2027. This report extensively covers market segmentation by distribution channel (offline and online), product (sanitary napkins, tampons, pantyliners, menstrual cups, and feminine hygiene wash), and geography (Europe, North America, APAC, South America, and Middle East and Africa).
Feminine hygiene wash market by distribution channel, end-user, and geography – Forecast and analysis 2023-2027: The feminine hygiene wash market size is expected to increase by USD 121.55 million from 2022 to 2027. This market is segmented by distribution channel (offline and online), end-user (female teenagers and female adults), and geography (APAC, North America, Europe, South America, and Middle East and Africa).
Female Contraceptive Market Scope | |
Report Coverage | Details |
Page number | 168 |
Base year | 2022 |
Historical year | 2017-2021 |
Forecast period | 2023-2027 |
Growth momentum & CAGR | Accelerate at a CAGR of 5.32% |
Market growth 2023-2027 | USD 5,142.22 million |
Market structure | Fragmented |
YoY growth 2022-2023 (%) | 4.2 |
Regional analysis | North America, APAC, Europe, South America, and Middle East and Africa |
Performing market contribution | North America at 38% |
Key consumer countries | US, Canada, China, Japan, and France |
Competitive landscape | Leading companies, market positioning of vendors, competitive strategies, and industry risks |
Companies profiled | AbbVie Inc., Afaxys Pharma LLC, Agile Therapeutics Inc., Amgen Inc., Ansell Ltd., Bayer AG, CooperSurgical Inc., Cupid Ltd., Exeltis USA Inc., Johnson & Johnson, Mayer Laboratories Inc., Medisafe Distribution Inc., Merck & Co. Inc., Mylan NV, Pfizer Inc., Piramal Enterprises Ltd., Reckitt Benckiser Group PLC, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Veru Inc. |
Market dynamics | Parent market analysis; market growth inducers and obstacles; fast-growing and slow-growing segment analysis for the forecast period. |
Customization purview | If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Browse for Technavio’s consumer staples market reports
Table of contents:
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Distribution Channel
- Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 13: Market segments
- 3.3 Market size 2022
- 3.4 Market outlook: Forecast for 2022-2027
- Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
- Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
- 4.1 Global female contraceptive market 2017 – 2021
- Exhibit 18: Historic Market Size – Data Table on Global female contraceptive market 2017 – 2021 ($ million)
- 4.2 Distribution Channel Segment Analysis 2017 – 2021
- Exhibit 19: Historic Market Size – Distribution Channel Segment 2017 – 2021 ($ million)
- 4.3 Product Segment Analysis 2017 – 2021
- Exhibit 20: Historic Market Size – Product Segment 2017 – 2021 ($ million)
- 4.4 Geography Segment Analysis 2017 – 2021
- Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
- 4.5 Country Segment Analysis 2017 – 2021
- Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
5 Five Forces Analysis
- 5.1 Five forces summary
- Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
- 5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
- 5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
- 5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
- 5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
- 5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
- 5.7 Market condition
- Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
6 Market Segmentation by Distribution Channel
- 6.1 Market segments
- Exhibit 30: Chart on Distribution Channel – Market share 2022-2027 (%)
- Exhibit 31: Data Table on Distribution Channel – Market share 2022-2027 (%)
- 6.2 Comparison by Distribution Channel
- Exhibit 32: Chart on Comparison by Distribution Channel
- Exhibit 33: Data Table on Comparison by Distribution Channel
- 6.3 Offline – Market size and forecast 2022-2027
- Exhibit 34: Chart on Offline – Market size and forecast 2022-2027 ($ million)
- Exhibit 35: Data Table on Offline – Market size and forecast 2022-2027 ($ million)
- Exhibit 36: Chart on Offline – Year-over-year growth 2022-2027 (%)
- Exhibit 37: Data Table on Offline – Year-over-year growth 2022-2027 (%)
- 6.4 Online – Market size and forecast 2022-2027
- Exhibit 38: Chart on Online – Market size and forecast 2022-2027 ($ million)
- Exhibit 39: Data Table on Online – Market size and forecast 2022-2027 ($ million)
- Exhibit 40: Chart on Online – Year-over-year growth 2022-2027 (%)
- Exhibit 41: Data Table on Online – Year-over-year growth 2022-2027 (%)
- 6.5 Market opportunity by Distribution Channel
- Exhibit 42: Market opportunity by Distribution Channel ($ million)
7 Market Segmentation by Product
- 7.1 Market segments
- Exhibit 43: Chart on Product – Market share 2022-2027 (%)
- Exhibit 44: Data Table on Product – Market share 2022-2027 (%)
- 7.2 Comparison by Product
- Exhibit 45: Chart on Comparison by Product
- Exhibit 46: Data Table on Comparison by Product
- 7.3 Female contraceptive devices – Market size and forecast 2022-2027
- Exhibit 47: Chart on Female contraceptive devices – Market size and forecast 2022-2027 ($ million)
- Exhibit 48: Data Table on Female contraceptive devices – Market size and forecast 2022-2027 ($ million)
- Exhibit 49: Chart on Female contraceptive devices – Year-over-year growth 2022-2027 (%)
- Exhibit 50: Data Table on Female contraceptive devices – Year-over-year growth 2022-2027 (%)
- 7.4 Female contraceptive drugs – Market size and forecast 2022-2027
- Exhibit 51: Chart on Female contraceptive drugs – Market size and forecast 2022-2027 ($ million)
- Exhibit 52: Data Table on Female contraceptive drugs – Market size and forecast 2022-2027 ($ million)
- Exhibit 53: Chart on Female contraceptive drugs – Year-over-year growth 2022-2027 (%)
- Exhibit 54: Data Table on Female contraceptive drugs – Year-over-year growth 2022-2027 (%)
- 7.5 Market opportunity by Product
- Exhibit 55: Market opportunity by Product ($ million)
8 Customer Landscape
- 8.1 Customer landscape overview
- Exhibit 56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
- 9.1 Geographic segmentation
- Exhibit 57: Chart on Market share by geography 2022-2027 (%)
- Exhibit 58: Data Table on Market share by geography 2022-2027 (%)
- 9.2 Geographic comparison
- Exhibit 59: Chart on Geographic comparison
- Exhibit 60: Data Table on Geographic comparison
- 9.3 North America – Market size and forecast 2022-2027
- Exhibit 61: Chart on North America – Market size and forecast 2022-2027 ($ million)
- Exhibit 62: Data Table on North America – Market size and forecast 2022-2027 ($ million)
- Exhibit 63: Chart on North America – Year-over-year growth 2022-2027 (%)
- Exhibit 64: Data Table on North America – Year-over-year growth 2022-2027 (%)
- 9.4 Europe – Market size and forecast 2022-2027
- Exhibit 65: Chart on Europe – Market size and forecast 2022-2027 ($ million)
- Exhibit 66: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
- Exhibit 67: Chart on Europe – Year-over-year growth 2022-2027 (%)
- Exhibit 68: Data Table on Europe – Year-over-year growth 2022-2027 (%)
- 9.5 APAC – Market size and forecast 2022-2027
- Exhibit 69: Chart on APAC – Market size and forecast 2022-2027 ($ million)
- Exhibit 70: Data Table on APAC – Market size and forecast 2022-2027 ($ million)
- Exhibit 71: Chart on APAC – Year-over-year growth 2022-2027 (%)
- Exhibit 72: Data Table on APAC – Year-over-year growth 2022-2027 (%)
- 9.6 South America – Market size and forecast 2022-2027
- Exhibit 73: Chart on South America – Market size and forecast 2022-2027 ($ million)
- Exhibit 74: Data Table on South America – Market size and forecast 2022-2027 ($ million)
- Exhibit 75: Chart on South America – Year-over-year growth 2022-2027 (%)
- Exhibit 76: Data Table on South America – Year-over-year growth 2022-2027 (%)
- 9.7 Middle East and Africa – Market size and forecast 2022-2027
- Exhibit 77: Chart on Middle East and Africa – Market size and forecast 2022-2027 ($ million)
- Exhibit 78: Data Table on Middle East and Africa – Market size and forecast 2022-2027 ($ million)
- Exhibit 79: Chart on Middle East and Africa – Year-over-year growth 2022-2027 (%)
- Exhibit 80: Data Table on Middle East and Africa – Year-over-year growth 2022-2027 (%)
- 9.8 US – Market size and forecast 2022-2027
- Exhibit 81: Chart on US – Market size and forecast 2022-2027 ($ million)
- Exhibit 82: Data Table on US – Market size and forecast 2022-2027 ($ million)
- Exhibit 83: Chart on US – Year-over-year growth 2022-2027 (%)
- Exhibit 84: Data Table on US – Year-over-year growth 2022-2027 (%)
- 9.9 China – Market size and forecast 2022-2027
- Exhibit 85: Chart on China – Market size and forecast 2022-2027 ($ million)
- Exhibit 86: Data Table on China – Market size and forecast 2022-2027 ($ million)
- Exhibit 87: Chart on China – Year-over-year growth 2022-2027 (%)
- Exhibit 88: Data Table on China – Year-over-year growth 2022-2027 (%)
- 9.10 France – Market size and forecast 2022-2027
- Exhibit 89: Chart on France – Market size and forecast 2022-2027 ($ million)
- Exhibit 90: Data Table on France – Market size and forecast 2022-2027 ($ million)
- Exhibit 91: Chart on France – Year-over-year growth 2022-2027 (%)
- Exhibit 92: Data Table on France – Year-over-year growth 2022-2027 (%)
- 9.11 Canada – Market size and forecast 2022-2027
- Exhibit 93: Chart on Canada – Market size and forecast 2022-2027 ($ million)
- Exhibit 94: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
- Exhibit 95: Chart on Canada – Year-over-year growth 2022-2027 (%)
- Exhibit 96: Data Table on Canada – Year-over-year growth 2022-2027 (%)
- 9.12 Japan – Market size and forecast 2022-2027
- Exhibit 97: Chart on Japan – Market size and forecast 2022-2027 ($ million)
- Exhibit 98: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
- Exhibit 99: Chart on Japan – Year-over-year growth 2022-2027 (%)
- Exhibit 100: Data Table on Japan – Year-over-year growth 2022-2027 (%)
- 9.13 Market opportunity by geography
- Exhibit 101: Market opportunity by geography ($ million)
10 Drivers, Challenges, and Trends
- 10.1 Market drivers
- 10.2 Market challenges
- 10.3 Impact of drivers and challenges
- Exhibit 102: Impact of drivers and challenges in 2022 and 2027
- 10.4 Market trends
11 Vendor Landscape
- 11.1 Overview
- 11.2 Vendor landscape
- Exhibit 103: Overview on Criticality of inputs and Factors of differentiation
- 11.3 Landscape disruption
- Exhibit 104: Overview on factors of disruption
- 11.4 Industry risks
- Exhibit 105: Impact of key risks on business
12 Vendor Analysis
- 12.1 Vendors covered
- Exhibit 106: Vendors covered
- 12.2 Market positioning of vendors
- Exhibit 107: Matrix on vendor position and classification
- 12.3 AbbVie Inc.
- Exhibit 108: AbbVie Inc. – Overview
- Exhibit 109: AbbVie Inc. – Product / Service
- Exhibit 110: AbbVie Inc. – Key offerings
- 12.4 Afaxys Pharma LLC
- Exhibit 111: Afaxys Pharma LLC – Overview
- Exhibit 112: Afaxys Pharma LLC – Product / Service
- Exhibit 113: Afaxys Pharma LLC – Key offerings
- 12.5 Agile Therapeutics Inc.
- Exhibit 114: Agile Therapeutics Inc. – Overview
- Exhibit 115: Agile Therapeutics Inc. – Product / Service
- Exhibit 116: Agile Therapeutics Inc. – Key offerings
- 12.6 Ansell Ltd.
- Exhibit 117: Ansell Ltd. – Overview
- Exhibit 118: Ansell Ltd. – Business segments
- Exhibit 119: Ansell Ltd. – Key news
- Exhibit 120: Ansell Ltd. – Key offerings
- Exhibit 121: Ansell Ltd. – Segment focus
- 12.7 Bayer AG
- Exhibit 122: Bayer AG – Overview
- Exhibit 123: Bayer AG – Business segments
- Exhibit 124: Bayer AG – Key offerings
- Exhibit 125: Bayer AG – Segment focus
- 12.8 CooperSurgical Inc.
- Exhibit 126: CooperSurgical Inc. – Overview
- Exhibit 127: CooperSurgical Inc. – Product / Service
- Exhibit 128: CooperSurgical Inc. – Key offerings
- 12.9 Cupid Ltd.
- Exhibit 129: Cupid Ltd. – Overview
- Exhibit 130: Cupid Ltd. – Product / Service
- Exhibit 131: Cupid Ltd. – Key offerings
- 12.10 Johnson and Johnson
- Exhibit 132: Johnson and Johnson – Overview
- Exhibit 133: Johnson and Johnson – Business segments
- Exhibit 134: Johnson and Johnson – Key news
- Exhibit 135: Johnson and Johnson – Key offerings
- Exhibit 136: Johnson and Johnson – Segment focus
- 12.11 Mayer Laboratories Inc.
- Exhibit 137: Mayer Laboratories Inc. – Overview
- Exhibit 138: Mayer Laboratories Inc. – Product / Service
- Exhibit 139: Mayer Laboratories Inc. – Key offerings
- 12.12 Merck and Co. Inc.
- Exhibit 140: Merck and Co. Inc. – Overview
- Exhibit 141: Merck and Co. Inc. – Business segments
- Exhibit 142: Merck and Co. Inc. – Key news
- Exhibit 143: Merck and Co. Inc. – Key offerings
- Exhibit 144: Merck and Co. Inc. – Segment focus
- 12.13 Mylan NV
- Exhibit 145: Mylan NV – Overview
- Exhibit 146: Mylan NV – Business segments
- Exhibit 147: Mylan NV – Key offerings
- Exhibit 148: Mylan NV – Segment focus
- 12.14 Pfizer Inc.
- Exhibit 149: Pfizer Inc. – Overview
- Exhibit 150: Pfizer Inc. – Product / Service
- Exhibit 151: Pfizer Inc. – Key news
- Exhibit 152: Pfizer Inc. – Key offerings
- 12.15 Reckitt Benckiser Group PLC
- Exhibit 153: Reckitt Benckiser Group PLC – Overview
- Exhibit 154: Reckitt Benckiser Group PLC – Business segments
- Exhibit 155: Reckitt Benckiser Group PLC – Key offerings
- Exhibit 156: Reckitt Benckiser Group PLC – Segment focus
- 12.16 Teva Pharmaceutical Industries Ltd.
- Exhibit 157: Teva Pharmaceutical Industries Ltd. – Overview
- Exhibit 158: Teva Pharmaceutical Industries Ltd. – Business segments
- Exhibit 159: Teva Pharmaceutical Industries Ltd. – Key news
- Exhibit 160: Teva Pharmaceutical Industries Ltd. – Key offerings
- Exhibit 161: Teva Pharmaceutical Industries Ltd. – Segment focus
- 12.17 Veru Inc.
- Exhibit 162: Veru Inc. – Overview
- Exhibit 163: Veru Inc. – Business segments
- Exhibit 164: Veru Inc. – Key offerings
- Exhibit 165: Veru Inc. – Segment focus
13 Appendix
- 13.1 Scope of the report
- 13.2 Inclusions and exclusions checklist
- Exhibit 166: Inclusions checklist
- Exhibit 167: Exclusions checklist
- 13.3 Currency conversion rates for US$
- Exhibit 168: Currency conversion rates for US$
- 13.4 Research methodology
- Exhibit 169: Research methodology
- Exhibit 170: Validation techniques employed for market sizing
- Exhibit 171: Information sources
- 13.5 List of abbreviations
- Exhibit 172: List of abbreviations
About us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
View original content to download multimedia:https://www.prnewswire.com/news-releases/female-contraceptive-market-size-to-grow-by-usd-5-142-22-million-personal-products-industry-is-the-parent-market–technavio-301699044.html
SOURCE Technavio